Abstract

Tranexamic acid (TXA) is widely used in various surgical settings to prevent bleeding. Despite extensive evidence supporting its safety and efficacy in many procedures, including hip fracture surgery, it is still largely underused. TXA could be given orally, intravenously or topically pre-, intra- and/or postoperatively. It has been shown to reduce blood transfusions and also to shorten hospital stays. Low doses are efficient. Almost all patients with hip fracture should receive TXA.

Downloads

Authors

Sigismond Lasocki - Département Anesthésie Réanimation, CHU Angers, Université d’Angers, Angers, France

Maëva Campfort - Département Anesthésie Réanimation, CHU Angers, Université d’Angers, Angers, France https://orcid.org/0000-0002-1382-1997

Maxime Léger - Département Anesthésie Réanimation, CHU Angers, Université d’Angers, Angers, France https://orcid.org/0000-0002-5447-6595

Emmanuel Rineau - Département Anesthésie Réanimation, CHU Angers, Université d’Angers, Angers, France https://orcid.org/0000-0003-1293-1120

  • Abstract viewed - 11 times
  • pdf downloaded - 5 times